With successful backgrounds in business, finance, medicine and science, our founders and managerial team are leading the way in the development of delirium risk prediction and diagnosis. Our international team has a unique combination of skills and professional experience from the medical, neuroscience, clinical research, biostatistics, artificial intelligence (AI) and business management sectors. We work closely with key opinion leaders and we are always striving to establish new improve delirium prognosis, diagnosis and prevention through informed research into deep-tech and AI solutions.
CO-FOUNDER
& Chief Executive Officer
Serial entrepreneur, 16 years founding and growing technology-based companies. Several board mandates. Experienced in lean startup, operational management, structuring, strategic planning, raising capital. 1 successful exit and 3 ventures in various stages of growth.
CO-FOUNDER
& Chief Medical Officer
Medical degree from Lausanne medical University, Anesthesiology and Intensive Care Medicine Specialist (FMH), Specialist in Diving and Hyperbaric oxygen Medicine (SUHMS) and Emergency Medicine (SGNOR). Over 14 years of medical practice.
CO-FOUNDER
& Chief Scientific Officer
Keen and entrepreneurial life scientist. Passionate about brain health. DPhil from Oxford in cell biology. I2I Fellow at Oxford Universities Saïd Business School. Winner of EIT Health PhD Transition Fellowship. Experience in big Pharma (Roche & Pfizer) and biotech (R-Biopharm).
Head of Research & Medical/
Grant Writer
PhD in Human Molecular Genetics.Master in Public Health (MPH).Highly experienced Clinical Research Scientist, Lecturer and Clinical Operations Manager.
Chief Technology Officer
Master of Science, MSc. in Information Systems from University of Zurich, years of experience from Accenture Digital Health in combining technology & data, medicine, and business to bring to market novel digital health offerings for improved patient outcomes
Head of Sales
Sales and business development professional. PhD in Molecular and Cellular Neurobiology, Goethe University of Frankfurt. Experience in pharma and biotech (Roche & 3Brain). Skilled in strategic planning, market research, and fostering strong relationships.
Chief Financial Officer
Master of Arts, HSG. SME Coach and Advisor at Dept. of Economics (AWA-ZH). Board member of UCON AG, CHFL AG and Kuokoa AG. Researcher in big-data & company valuations. Lecturer in accounting, economics and law.
Data & AI Scientist
MSc in Data Science for Healthcare from University of Trieste, currently pursuing a PhD at KU Leuven; focusing on Interpretable Machine Learning for Healthcare. Bsc in Bionformatics. Extensive experience with medical data. Skilled in designing & developing machine learning models that support clinical decision-making and enhance healthcare outcomes.
Senior Software Developer
Bachelor of Science, BSc, in Informatics with specialisation in Information Systems. Experienced data analyst and integration specialist.
Robotic Process Automation enthusiast with exposure to various platforms.
Content Creator / Product Management
Graduate student at the University of Zurich with a BA in Anglistics.
Chief Cuddling Officer
Cuddling assistant – 5 years of cuddling experience. Supports the Chief Cuddling Officer in reducing employee stress, boosting office morale, promoting productivity, improving communication, and making the workplace appear more attractive.
Chief Cuddling Officer - Advisor
Cuddling expert – 12 years of cuddling experience. Helps reduce employee stress, boost office morale, promote productivity, improve communication, encourage a healthier lifestyle, makes the workplace appear more attractive.
Our Advisors come from across the globe and are key opinion leaders in medicine – including delirium, Anaesthesiology, Perioperative Medicine, Internal Medicine, Intensive Care Medicine – medical ethics, business, supercomputing, healthcare and life sciences.
Chief Innovation Advisor
Intensive care physician, critical surgical, neurological illnesses& injuries. Specialised in traumatic brain injury, stroke, encephalopathy. Associate Prof., Director of Precision Medicine & Chief of the Division of Informatics, Integration & Innovation, Associate Director of the Johns Hopkins Precision Medicine Center in Neurocritical Care.
Medical Advisor & KOL
Lisbeth Evered is the Scientific Head of Research in the Department of Anaesthesia, St. Vincent’s Hospital Melbourne. Lisbeth is a founding member of the Centre for Anaesthesia and Cognitive Function at St. Vincent’s Hospital Melbourne. In 2011 she founded and continues to Chair the Perioperative Cognition Professional Interest Area (PIA) of the Alzheimer’s Association (US) International Society to Advance Alzheimer’s Research and Treatment (ISTAART).
Medical Advisor & KOL
John & Terry Levin Family Professor of Medicine, Professor of Psychiatry and, by courtesy, of Internal Medicine, Surgery, Emergency Medicine & Law Chief, Division of Med. Psychiatry, Med. Director, Consultation-Liaison Psychiatry & Psychosomatic Medicine Chief, Emergency Psychiatry Service & Disaster Psychiatry Chief, Critical Care Psychiatry Service
Medical Advisor & KOL
Luzius Steiner is Chief Physician and Head of Anesthesia at the University Hospital Basel. Luzius has led several clinical studies focusing on causes and prevention of memory disorders/confusional states in elderly patients after surgery or in the ICU. His research makes him an important authority in the field of postoperative delirium and postoperative cognitive dysfunction.
Medical Advisor & KOL
Rebecca von Haken is an anesthesiologist and the head of the German Delirium Network (Deutsches Delir Netzwerk) and is setting up a new intermediate care unit at the Universitätsklinikum Mannheim. She has contributed to numerous scientific and news articles about postoperative delirium. Articles in e.g. the popular German newspaper DIE WELT have increased awareness of the problem.
Medical Advisor
Henry Perschak is the former Head of Internal Medicine and the International Medical Center at the Klinik Hirslanden in Zurich. Currently he runs a practice for Internal Medicine and Personalized Health. He has a keen personal interest in improving patient care and follow-up. Passionate about brain health, Henry helps PIPRA to fit into the existing clinical pathways.
Medical & Ethics Advisor
Reto Stocker is the Chief Physician in Intensive Care and Anaesthesiology at the Klinik Hirslanden in Zurich. Reto is also scientific head of the Clinical Trial Unit of Hirslanden Corporation and member of the cantonal ethics commission. During his career, he has seen many cases of POD and POCD, which has fuelled his ambition to improve the standard of care.
Business Advisor
Saskia Karg works as project leader for the Therapy Development Accelerator of the University of Zurich, helping academic start-ups form, grow, and thrive. Saskia has a PhD in biotechnology from ETH Zurich, eight years of work experience in biotech (in a highly successful spin-off of ETH Zurich as well as in a listed company) and eight years of work experience in research hospitals. She has long-term experience volunteering as a patient advocate and is a professionally trained coach. Her uniquely broad experience in translational medicine allows her to integrate the various stakeholder perspectives needed to make a product successful.
KOL & Independent Advisor
Alasdair MacLullich is an independent advisor to PIPRA and key opinion leader in the field of delirium. He holds a professorship in Geriatric Medicine and is a consultant physician in the Royal Infirmary of Edinburgh. He is well-known as the main author of the 4AT delirium assessment tool, one of the best-validated delirium assessment tools globally. Alasdair co-founded the European Delirium Association in 2006 and the Scottish Delirium Association in 2011. He co-chaired the committee which produced the Scottish Intercollegiate Guidelines Network guidelines on delirium, published in 2019.
Business Advisor
Karina Candrian is Co-Founder & Partner at MEDICALBOARD and Co-Founder & CEO at Effectum Medical AG. She is an Innosuisse Start-up Coach and a Member of the Board of Directors at Aquilana Versicherungen.Karina has over 20 years of ex-perience in the healthcare industry with main focus on MedTech industry. She has many years of business consulting experience and in various line functions from generating the product idea to marketing and selling of the product.
Medical Advisor
Senior Consultant in Anesthesiology at the University Hospital Basel. Research Group Leader and Principal Investigator in neuroanesthesia and perioperative neurocognitive disorders at the University of Basel.
Business Advisor
Jorge Fernandez Garcia is the Director of Innovation and member of the Management Board of EIT Health. He has more than 20 years of experience in healthcare and life sciences, the last ten years fully dedicated to innovation, technology, and entrepreneurship, at the intersection of business, government, and academia.He regularly acts as advisor and mentor to healthcare startups and entrepreneurial acceleration programs.
Business Advisor
Dr. Jürg Wittwer is CEO of the Touring Club Suisse, the leading automotive club in Switzerland with 1.5 million members and 1700 employees. He completed his studies at the University of St. Gallen with a doctorate in business administration. He is a seasoned international insurance executive and managed insurance and assistance companies in Switzerland, Spain, Portugal, Germany, Canada and the USA. In addition to his activities at TCS, Jürg Wittwer is a guest lecturer on the subject of intercultural management at various Universities.
Business Advisor
Peter Schmid has founded several companies and is an experienced specialist in fundraising, start-up growth, digitalization and operational excellence. He acts as an Investor and Advisor to Start-ups, Investors and Corporations.After having spent 20 years in Management Consulting where he was a Partner in different global firms, he discovered the Silicon Valley and became an enthusiastic Entrepreneur and Digitalist.Peter has worked with PIPRA over the last 2 years and is fascinated by the life-saving solution as well as the formidable team.
Technical Advisor
Since 2009 Christof Bühler leads the department «Life Science and Physics» at Supercomputing Systems AG. He has 25+ years of engineering & research experience in electronics, software, vision & sensor systems, optics, lasers, micro-technology and algorithms. His interdisciplinary expertise is in system design & integration, computer & information technologies, biotechnology, medical devices, sensors, computer vision, fast data processing, statistics and artificial intelligence.
External Expert in the Field
30 years of experience in the healthcare industry. PhD in Technical Sciences and a Master in Industrial Management from Federal Institute of Technology, Zurich. Founder of Klinik Hirslanden AG (formerly Hirslanden Holding Group) and served as CEO from 1990-2008. Served as VP of the Board at Klinik Hirslanden AG and a Director since June 2001. Formerly: CEO of Medi-Clinic -Switzerland AG. Co-Founder of Rhino Partners. Board Member of Hirslanden Investments SA since 2003 and Grand Hotels Bad Ragaz AG since 2005. Director of MEDIAN Kliniken GmbH since 2010.
Representing the Investors
Completed his doctoral studies in economics at the University of Basel, obtaining his Dr. Rer. Pol in 1983, he started out his career in marketing before switching to the financial sector and finally directing several divisions of Kraft Foods in Zürich, Chicago and Paris. After completing different mandates as a CFO resp. as a CEO for various companies in the San Francisco area, he has since July 2001 been active as an independent Private Equity Investor and Business Angel. Moreover, he is not only on the board of CTI Invest but also a board member resp. chairman of the board for several Swiss companies. In 2009 he was awarded «Swiss Business Angel of the Year 2009» by SECA.
Representing the Founders
Serial entrepreneur, 16 years founding and growing technology-based companies. Several board mandates. Experienced in lean startup, operational management, structuring, strategic planning, raising capital. 1 successful exit and 3 ventures in various stages of growth.
Our solution supports clinicians with objective stratification of pre-surgical patients into risk groups. Knowing which patients are at risk of postoperative complications can help reduce the incidence dramatically, improving patient outcomes and reducing costs to hospitals, insurers, patients and society at large
We trust and respect one another. We work together, learn together and achieve great things together.
We are kind and caring to each other and to everyone we meet.
We love what we do, and we truly believe in why we are doing it.
We know our products will make a positive difference to patients and their families.
We believe in taking the initiative and delivering work that we are proud of.
We listen to – and value – each other’s thoughts, ideas and feedback.
We respect the principles of medical ethics and always act withintegrity.
We believe honesty creates a positive atmosphere.
